$49.3 Bn GLP-1 Markets 2024-2035 with Boehringer Ingelheim, Eli Lilly, Novo Nordisk Dominating
Market: Industry Trends and Global Forecasts to 2035: Distribution by Type of Molecule, Active Compound Used, Type of GLP-1 ...
Becker's Hospital Review11h
Patients sue over alleged stomach paralysis linked to Ozempic, Mounjaro
Dana Filmore, a grandmother from Columbus, Ohio, is among thousands of plaintiffs filing a federal lawsuit against pharmaceutical companies Novo Nordisk and Eli Lilly, alleging Ozempic and Mounjaro ...
Alarm as unsuspecting Australians buy dangerous Ozempic dupes
An Australian woman has suffered critical complications from a counterfeit Ozempic drug, as authorities reveal more fakes ...
verywellhealth14h
Why Is Ozempic So Expensive? Novo Nordisk Blames Prescription Drug Middlemen
"Pharmacy middlemen" are to blame for the high cost of drugs like Wegovy and Ozempic, according to Novo Nordisk's CEO. Is ...
Novo Nordisk (NVO) Poised for 23.3% Upside as Obesity Market Expands and Clinical Trials Impress
We recently published a list of 10 Best Major Stocks to Invest In According to Analysts. In this article, we are going to ...
Opinion
The Columbian20hOpinion
Jarvis: High weight loss drug costs hurt
On Tuesday, congressional leaders spent two hours taking to task Novo Nordisk Chief Executive Officer Lars Fruergaard Jørgensen over the high price of the company’s diabetes and obesity drugs, Ozempic ...